Australia markets open in 2 hours 27 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
56.52+1.08 (+1.95%)
At close: 04:00PM EDT
56.52 0.00 (0.00%)
After hours: 04:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.40B
Enterprise value 5.56B
Trailing P/E 24.96
Forward P/E 15.27
PEG ratio (5-yr expected) 1.53
Price/sales (ttm)2.89
Price/book (mrq)2.44
Enterprise value/revenue 3.57
Enterprise value/EBITDA 14.56

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 3-13.73%
S&P500 52-week change 3-11.09%
52-week high 366.59
52-week low 340.67
50-day moving average 356.10
200-day moving average 352.90

Share statistics

Avg vol (3-month) 3494.15k
Avg vol (10-day) 3464.95k
Shares outstanding 581.64M
Implied shares outstanding 6N/A
Float 870.58M
% held by insiders 113.34%
% held by institutions 195.00%
Shares short (14 Mar 2023) 43.85M
Short ratio (14 Mar 2023) 46.58
Short % of float (14 Mar 2023) 46.33%
Short % of shares outstanding (14 Mar 2023) 44.72%
Shares short (prior month 14 Feb 2023) 45.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 11.59%
Operating margin (ttm)17.51%

Management effectiveness

Return on assets (ttm)4.44%
Return on equity (ttm)10.35%

Income statement

Revenue (ttm)1.56B
Revenue per share (ttm)18.77
Quarterly revenue growth (yoy)-1.90%
Gross profit (ttm)982.03M
Net income avi to common (ttm)180.55M
Diluted EPS (ttm)2.17
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)473.34M
Total cash per share (mrq)5.8
Total debt (mrq)1.62B
Total debt/equity (mrq)89.52
Current ratio (mrq)3.62
Book value per share (mrq)21.57

Cash flow statement

Operating cash flow (ttm)264.47M
Levered free cash flow (ttm)203.5M